Our health economics team has developed cost-effectiveness and budget impact models for many of the world's leading pharmaceutical and medical device companies.
Our expert team of experienced, in-house health economic modelers are adept at developing a wide range of economic tools, including decision-tree models, Markov models, patient-level simulations and highly efficient functionality for full deterministic and probabilistic sensitivity analyses.
Key health economic services include:
- Global economic modelling & country adaptations
- Cost-effectiveness/ cost minimization analysis
- Budget impact modelling
- Health economic strategy & onsite training publications